- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02880761
Cohort Study on A Following-up System of Native Arteriovenous Fistulae
Cohort Study on A Following-up System of Native Arteriovenous Fistulae in Chinese Patients Treated by Maintenance Hemodialysis
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The Following-up System of AVF includes 3 stages. In the 1st stage, before AVF surgery operation, the contents of Following-up System of AVF include history, physical exam, ultrasonography detection. The assesment results will guide the methods of the AVF surgery operation. In the 2nd stage, before AVF puncture firstly and 3 months after AVF operation, the contents of Following-up System of AVF include physical exam and ultrasonography detection. The results will help the nurses and doctors make a decision of the method of AVF puncture. In the 3rd stage, during the following 2 years after AVF puncture successfully, the contents include physical exam and ultrasonography detection regularly. The adequacy of hemodialysis by using AVF will be assessed by urea clearance index (Kt/V).
The data of patients in other hemodialysis centers will be recorded and compared to the patients in experiment group.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Beijing
-
Beijing, Beijing, China, 102206
- Peking University International Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Maintenance hemodialysis patients using AVF;
- Ages 18-70 years old;
- Agreement with frequent following-up.
Exclusion Criteria:
- Younger than 18 years or elder than 70 years;
- Cachexia;
- Acute renal failure;
- Exceptive life time less than 6 months;
- Pregnant or planning pregnant;
- Waiting for renal transplantation or transferring to peritoneal dialysis.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention
Patients with AVF will be followed up by a preset following-up system.
Interventions would be administered according to the assessment for AVF, which including the surgery and puncture of AVF.
For AVF surgery, a certain vein would be used in the operation according to the assessment results.
For AVF puncture, the methods, such as 'button hole', 'rope ladder', dwelling needle, would be selected prospectively according to the assessment results.
|
Assessment guiding surgery and puncture for AVF.
Assessing the parameters of vascular vessels during following-up and making suggestions on surgery and puncture of AVF
|
|
No Intervention: Control
Patients in other hemodialysis centers who are treated by routine protocal would be enrolled into control group.
Their clinical data would be collected and compared with intervention group.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of Participants With Fistula Failure
Time Frame: 3 months after surgery
|
The AVF can not be used for hemodialysis treatment 3 months after surgery, which it is defined as Primary Failure of AVF.
The primary failure of AVF is regarded as the primary outcome of the patients who were followed up.
The ratio of primary failure will be compared between two groups.
|
3 months after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Life Time of AVF
Time Frame: Equal to or larger than 2 years
|
The life time of an available AVF since the AVF is functionable.
The life time of an AVF is a period time from the AVF used for hemodialysis treatment at first time to the last time when the AVF can not be used for hemodialysis therapy,, whichever came first, assessed up to 48 months.
Since the AVF will be punctured in every hemodialysis session, the function of AVF were detected during every treatment session (3 times per week).
|
Equal to or larger than 2 years
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mean Value of Urea Clearance Index During 24 Months
Time Frame: 2 years
|
As a parameter of hemodialysis adequacy, urea clearance index (Kt/V) will be detected very month.
The Kt/V should be larger than 1.2 , which were regarded as being adequate in the hemodialysis session.
This parameter will be tested every month and the mean value were be calculated according to the records during 24 months.
Those who with Kt/V less than 1.2 for 3 times would be defined as the patient with unfunctional AVF.
The values of Kt/V in unfunctional AVF patients would not be used in statistic analysis.
|
2 years
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Chair: Dongliang Zhang, Doctor, Peking University Hospital
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2016-019
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Arteriovenous Fistulae
-
Centre hospitalier de l'Université de Montréal...Biotronik Canada IncCompletedArteriovenous Graft | Arteriovenous FistulaeCanada
-
N.M.B. Medical Applications LtdUnknownObstructive Lesions of Arteriovenous Dialysis FistulaeIsrael
-
N.M.B. Medical Applications LtdUnknownObstructive Lesions of Arteriovenous Dialysis FistulaeIsrael
-
Maastricht University Medical CenterMaastricht UniversityCompletedKidney Failure, Chronic | Arteriovenous FistulaeNetherlands
-
NHS Greater Glasgow and ClydeUnknownNeuropathic Pain | Arteriovenous FistulaeUnited Kingdom
-
University Paul Sabatier of ToulouseActive, not recruiting
-
Denver Health and Hospital Authority3MWithdrawnFistulaeUnited States
-
IpsenCompletedDigestive FistulaeFrance, Russian Federation
-
Ohio State UniversitySpiration, Inc.WithdrawnManagement of BPF (Bronchopleural Fistulae)United States
-
Wake Forest University Health SciencesCompleted
Clinical Trials on Assessment guiding surgery and puncture for AVF
-
Xiaolong Yan, Dr.Not yet recruitingPercutaneous Lung Ablation
-
John T. NosekCompletedIntellectual Disability | Autism Spectrum DisorderUnited States
-
Yonsei UniversityNot yet recruitingRadiation ExposureSouth Korea, Japan
-
Yonsei UniversityMyung In PharmCompletedRadiation ExposureSouth Korea
-
University of WashingtonNational Center for Complementary and Integrative Health (NCCIH); Henry Ford... and other collaboratorsActive, not recruiting
-
Dr Abdurrahman Yurtaslan Ankara Oncology Training...CompletedPostoperative Complications | Frailty | Aged, 80 and Over | Abdomen CancerTurkey (Türkiye)
-
Neuromed IRCCSRecruiting
-
Paris Brain Institute (ICM)Not yet recruitingNeurodegenerative DiseasesFrance
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaUnknownBowel Endometriosis | Endometriosis, RectumItaly